Table 2 Surgical outcomes of both groups
From: The Hemobag: the modern ultrafiltration system for patients undergoing cardiopulmonary by pass
Group Hemobag (n = 25) | Group Cell Washer (n = 25) | p | |
|---|---|---|---|
Cardiopulmonary bypass time (min) | 89.5 ± 46.1 | 93.1 ± 45.3 | 0.782 |
Cross-clamp time (min) | 63.3 ± 36.1 | 65.7 ± 39.4 | 0.823 |
Hours of intubation | 2.6 ± 1.9 | 2.3 ± 2.0 | 0.589 |
24 h postoperative bleeding (ml) | 462 ± 336 | 538 ± 430 | 0.490 |
Length of stay in ICU (days) | 1.5 ± 2.9 | 1.5 ± 1.9 | 1.000 |
Total length of stay (days) | 11.1 ± 10.1 | 11.6 ± 8.8 | 0.853 |
Hemoglobin at discharge (g/dl) | 11.5 ± 1.2 | 10.7 ± 2.0 | 0.093 |
Death | 1 (4%) | 1 (4%) | 1.000 |
Mean quantity of blood reinfused (ml) | 461 ± 174 | 410 ± 132 | 0.249 |
Patients receiving blood transfusion | 9 (36%) | 11 (44%) | 0.564 |
Patients receiving platelet transfusion | 3 (12%) | 5 (20%) | 0.702 |